Roivant Sciences (ROIV) Receivables (2021 - 2024)
Roivant Sciences' Receivables came in at $678,000 for fiscal Q3 2025 (quarter ended Dec 31, 2024), down 98.3% from $41.08 million a year earlier and down 64.6% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Receivables (2021 - 2024) Analysis & Trends
At the end of FY2024 (ended Mar 31, 2024), Roivant Sciences' Receivables was $3.99 million, down 86.9% from FY2023.
- Receivables carries a three-year compound annual growth rate of -29.2% (FY2021 to FY2024).
- Going back by fiscal year, Receivables was $30.38 million in FY2023 (+683.4%), $3.88 million in FY2022 (-65.4%) and $11.22 million in FY2021.
- The fiscal Q3 2025 figure represents the lowest quarterly Receivables in data going back to fiscal Q4 2021.
- Year-over-year, Receivables increased in four of the last seven quarters, with growth averaging 96.0%.
- The fastest year-over-year change in Receivables over five years came in fiscal Q4 2023 (growth of 683.4%), and the weakest in fiscal Q3 2025 (a decline of 98.3%).
- Business Quant data shows ROIV's Receivables at $1.92 million (Q2 2025), $79.79 million (Q1 2025) and $3.99 million (Q4 2024) in the three fiscal quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 678,000.00 |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 79.79 Mn |
| Mar 31, 2024 | 3.99 Mn |
| Dec 31, 2023 | 41.08 Mn |
| Sep 30, 2023 | 52.12 Mn |
| Jun 30, 2023 | 37.06 Mn |
| Mar 31, 2023 | 30.38 Mn |
| Dec 31, 2022 | 27.97 Mn |
| Sep 30, 2022 | 25.04 Mn |
| Mar 31, 2022 | 3.88 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 9.81 Mn |
| Jun 30, 2021 | 3.42 Mn |
| Mar 31, 2021 | 11.22 Mn |
API Access
Roivant Sciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();